MedPath

IMBRUVICA 280 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

IMBRUVICA 280 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Commercialized
Register Number

114945010

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Oct 24, 2019

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number114945010
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

IBRUTINIBActive
Quantity: 280 mg
Name: IBRUTINIB

ATC CLASSIFICATION (3)

L01E
L01EL
L01EL01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.